Definitive Contract HHSN272200500009C

This is a $20,654,816.99, cost-plus-fixed-fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to United Biomedical, Inc. for HIV vaccine design and development teams for prevention and treatment. The contract has a completion date of June 29, 2010 and was awarded on June 30, 2005. This contract is not associated with a set-aside and does not indicate the use of any small business program. United Biomedical, Inc. is a for-profit, self-certified small disadvantaged business organization. The place of performance is Hauppauge, New York.